17 January 2025
17 January 2025
Despite constraints exerted by GLP-1RAs on bariatric surgery volumes, shares in Intuitive Surgical surged following a positive 2024.
Evidity Health Capital spearheaded the funding round with new investor Accelmed Partners.
The new pan-European group of 73 regulators, companies and trial sites is backed by €66.8m in funding with a six-year goal.
SurGenTec asserts that the OsteoFlo HydroFiber may improve patient outcomes versus the use of allograft/autograft in spinal surgeries.
The technology of the test was licensed from the University of California, San Francisco.
Meridian’s DuoDote autoinjectors will be manufactured at the Missouri-based facility of Meridian's parent company Kindeva Drug Delivery.
The trial will enrol subjects across various US healthcare institutions.
The company’s one-year study demonstrated the superiority of the ReActiv8 system for treating chronic low back pain over the SoC.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
